News
Swiss Deep Tech News & Analysis
Stay informed on the Swiss technology landscape. This is your central resource for Deep Tech News, combining key developments from across the ecosystem with original, data-driven analysis from the Deep Tech Nation Foundation. We track and report on significant technological milestones, funding rounds, and research to provide a comprehensive overview for international investors, partners, and researchers.
Curated Newsfeed
-
Vaderis Therapeutics closes USD 152 million Series B Financing
startupticker.ch
-
Terra Quantum partners with Apex.AI on quantum-safe security
startupticker.ch
-
AB2 Bio receives USD 30 million from Nippon Shinyaku
startupticker.ch
DTN Highlights
-
Read more: swisscanto: A Matter of ScaleThe Flywheel Switzerland Hasn’t Built Roughly seventy percent of the Swiss Growth Fund’s money is invested in Switzerland, and Nils Granath is clear that this…
-
Read more: swisscanto: Backed to the FutureThree Companies That Almost Stopped Running Nils Granath invests in the growth stage of the Swiss market, and it is the part where the money…
-
Read more: swisscanto: At Face ValueThe Marathon Runner In the mid-1990s, the European mobile telecoms industry was hiring at a pace that was breaking its own buildings. Ericsson, the Swedish…
-
Read more: Swiss Venture Capital Steadies at $1.58 Billion in H1 2026 as Hardware Sets a RecordSwiss venture capital returned to a familiar level in the first half of 2026. Startups raised $1.58 billion (CHF 1.245 billion) across 123 financing rounds,…
-
Read more: Swiss Deep Tech Report 2026: Switzerland Leads the Technologies Reshaping the Global EconomyThe technologies now driving the global economy, advanced computing, artificial intelligence, and robotics, are built patiently, over decades of investment and scientific groundwork. So are…
-
Read more: Swiss Venture Capital Matures: Returns, Exits, and a Sharper Investor LayerSwiss venture capital recorded its first annual rebound since 2022 last year, with CHF 2.95 billion invested and a record CHF 1.116 billion flowing into…
-
Read more: Bridging the tough middle: Key takeaways from the Deep-Tech x Space SummitESA chose ESDI at Park Innovaare for its first dedicated Deep-Tech × Space Summit on 13 May 2026. Deep Tech Nation Switzerland CEO Joanne Sieber…
-
Read more: SICTIC: A Matter of ScaleIn Parts 1 and 2 of our series, we followed Thomas Dübendorfer from a student fund at ETH Zurich to SICTIC, Switzerland’s largest angel investor…
-
Read more: SICTIC: Backed to the FutureThomas Dübendorfer doesn’t invest like a portfolio manager optimizing for returns. He invests like a scout who found someone worth running alongside – and then…
-
CHF 39 million for BE WTR eco-friendly premium water solutions
BE WTR, the Swiss startup revolutionizing sustainable water solutions, just closed its CHF 39M Series C funding round. This new round of funding will accelerate BE…
startupticker.ch
startupticker.ch: CHF 39 million for BE WTR eco-friendly premium water solutions- BE WTR closed a CHF 39M Series C round led by Convent Capital to expand sustainable water solutions globally.
- The company operates compact on-site bottling plants in high-end venues, targeting over 20 locations by end-2025.
- BE WTR offers water activation and circular bottling as a sustainable alternative to traditional bottled water.
-
Lymphatica Medical raises €17.9 million in series B Funding
Lymphatica Medtech SA is a clinical-stage company based in Lausanne, specialized in innovative treatments for lymphedema, a chronic vascular condition that currently has no cure…
startupticker.ch
startupticker.ch: Lymphatica Medical raises €17.9 million in series B Funding- Lymphatica Medtech raised Series B funding to advance LymphoDrain, an implantable device for treating lymphedema.
- LymphoDrain is minimally invasive, implanted subcutaneously, and actively restores lymphatic vessel function.
- Dan Rose, former leader at LimFlow and Medtronic, joined as Chairman, strengthening the board.
-
€36 million to digitalise farming with xFarm’s platform
xFarm Technologies a Swiss-Italian startup dedicated to digitalising the agri-food sector, has raised €36 million in series C round. The funds will enable the company…
startupticker.ch
startupticker.ch: €36 million to digitalise farming with xFarm’s platform- xFarm supports 450,000+ farms across 100+ supply chains covering 7 million hectares using AI-powered data analysis and regenerative agriculture models.
- xFarm is creating a new Fintech and Insurtech division to enhance insurance and financial management services for farmers.
-
CHF 10 million to advance Somagenetix' first gene therapy candidate into a clinical trial
Somagenetix AG, a pioneering biotech company focussing on gene therapies for disorders affecting a type of white blood cells, raised CHF 10 million in a…
startupticker.ch
startupticker.ch: CHF 10 million to advance Somagenetix' first gene therapy candidate into a clinical trial- Somagenetix AG raised CHF 10M in Series A funding for SGX-001, a gene therapy for p47 Chronic Granulomatous Disease, targeting 2026 clinical trials.
- The company's lentiviral gene therapy platform offers a one-time treatment alternative to stem cell transplants for inherited immunodeficiencies.
- Dr. Andrin Oswald joined as CEO, bringing over 20 years of pharmaceutical leadership experience to guide clinical development.
-
FDA approvals and clinical advancements propel life sciences startups forward
Four startups are making strides in developing novel solutions for challenging medical conditions, potentially offering new hope for patients. Alentis Therapeutics and Abionic have received…
startupticker.ch
startupticker.ch: FDA approvals and clinical advancements propel life sciences startups forward- Alentis Therapeutics received FDA clearance for ALE.P02, an antibody-drug conjugate for CLDN1+ squamous cancers, with Phase 1/2 trials starting Q1 2025.
- Abionic's CAPSULE PSP test gained FDA approval for rapid sepsis detection in blood samples within five minutes, improving patient outcomes.
- Anokion's ANK-700 showed clinical proof of concept for treating relapsing-remitting multiple sclerosis by re-educating immune tolerance to myelin.
-
Voliro secures $12M in Series A funding to transform industrial inspections with drones
Voliro, a leading innovator in aerial mobile robotics, closed a $12 million in Series A funding round led by Cherry Ventures. The new funding will…
startupticker.ch
startupticker.ch: Voliro secures $12M in Series A funding to transform industrial inspections with drones- Voliro raised $12 million in Series A funding to expand aerial robotics for industrial inspection, maintenance, and repair work.
- Voliro's tiltable rotor drones enable non-destructive testing and contact-based inspections on hard-to-reach infrastructure.
- Voliro offers a B2B subscription model including hardware, software, training, support, and updates for customers.
-
Read more: Deep Tech Startups Drive Swiss InvestmentMore venture capital went to Swiss startups from deep tech sectors such as biopharma and hardware & robotics in 2024 than in 2023 – and…
-
Read more: New Information Platform Aims to Boost Funding for Swiss Deep Tech ScaleupsDeep Tech Nation Switzerland Foundation and Startupticker Foundation announce the launch of the Deep Tech Nation Information Platform, a digital portal meant to facilitate investments…
-
Read more: Fajer Mushtaq, Clean Tech EntrepreneurFajer Mushtaq, co-founder and CEO of Oxyle, has raised about CHF 9 million in non-dilutive funds in recent years from innovation programmes, the public sector…
-
Read more: Andreas Brenner, Serial EntrepeneurAndreas Brenner started at the age of 28, when he founded Avrios.com. He spent seven years as CEO responsible for building an SaaS platform that…
-
Read more: Switzerland, Big Pharma’s Shopping CentreThe top pharmaceutical companies are very active in Switzerland, participating in large financing rounds and acquiring companies or drug candidates. In 2024, the global number…
-
Read more: Robots and the Swiss Tradition of Customer Focus
For Swiss robotics startups, customer success and investor success go hand in hand. In addition to outstanding technology, this requires a high degree of customer…
